Development of a radionuclide-labeled monoclonal anti-CD55 antibody with theranostic potential in pleural metastatic lung cancer.
about
Development of a radionuclide-labeled monoclonal anti-CD55 antibody with theranostic potential in pleural metastatic lung cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Development of a radionuclide- ...... leural metastatic lung cancer.
@en
Development of a radionuclide- ...... leural metastatic lung cancer.
@nl
type
label
Development of a radionuclide- ...... leural metastatic lung cancer.
@en
Development of a radionuclide- ...... leural metastatic lung cancer.
@nl
prefLabel
Development of a radionuclide- ...... leural metastatic lung cancer.
@en
Development of a radionuclide- ...... leural metastatic lung cancer.
@nl
P2093
P2860
P1433
P1476
Development of a radionuclide- ...... pleural metastatic lung cancer
@en
P2093
Chaeuk Chung
Eun Ha Cho
Jae Cheong Lim
Ji Young Kim
Jichul Lee
Lark Kyun Kim
So-Young Lee
Soo Yong Kim
Sung Hee Jung
Sung-Won Min
P2860
P356
10.1038/S41598-018-27355-8
P407
P50
P577
2018-06-12T00:00:00Z